Salicyluric Acid

Salicyluric Acid

SCHEMBL29935452

O=C(O)CNC(=O)c1ccccc1O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.58
HTT P42858 3/20 0.58
HSD17B10 Q99714 3/20 0.58
NPC1 O15118 3/20 0.58
ALDH1A1 P00352 3/20 0.58
MAPT P10636 2/20 0.58
TSHR P16473 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
NLRP1 Q9C000 1/20 0.58
KDM4E B2RXH2 6/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
GAA P10253 2/20 0.57
MPO P05164 1/20 0.57
HIF1A Q16665 1/20 0.57
LMNA P02545 2/20 0.56
TP53 P04637 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
FTO Q9C0B1 2/20 0.56
EGLN2 Q96KS0 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salicyluric Acid SCHEMBL570541 1.00 HPGD (0.58) HPGDHTTHSD17B10NPC1ALDH1A1
SCHEMBL4952951 0.89 LMNA (0.63) HPGDHTTHSD17B10NPC1ALDH1A1
SCHEMBL31448014 0.88 KEAP1 (0.62) HTTMAPTTSHRKDM4EGAA
SCHEMBL3677100 0.87 ALOX5 (0.64) HPGDHTTHSD17B10NPC1ALDH1A1
SCHEMBL29387023 0.87 ALOX5 (0.64) HPGDHTTHSD17B10NPC1ALDH1A1
SCHEMBL14839314 0.85 HPGD (0.55) HPGDHTTHSD17B10NPC1ALDH1A1
SCHEMBL7325670 0.84 KDM4E (0.61) HPGDHTTHSD17B10NPC1ALDH1A1
SCHEMBL23014512 0.84 HPGD (0.54) HPGDHTTHSD17B10NPC1ALDH1A1
SCHEMBL12562532 0.83 NAAA (0.57) HPGDHTTHSD17B10NPC1ALDH1A1
SCHEMBL3082099 0.83 CA1 (0.56) HPGDHTTHSD17B10NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4429704-A1 IONIC LIQUID COMPOSITIONS I2O Therapeutics, Inc. (US) 2024-09-18 EP claimed
EP-3321686-B1 BIOMARKERS RELATED TO INSULIN RESISTANCE PROGRESSION AND METHODS USING THE SAME METABOLON INC (US) 2024-03-13 EP claimed
WO-2023086499-A1 IONIC LIQUID COMPOSITIONS I2O THERAPEUTICS, INC. (US) 2023-05-19 WO claimed
WO-2024243289-A2 GUT MICROBE DERIVED AROMATIC AMINO ACID METABOLITES FOR DETECTION AND TREATMENT OF DISEASE THE CLEVELAND CLINIC FOUNDATION (US) 2024-11-28 WO disclosed
EP-4457513-A1 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE Société des Produits Nestlé S.A. (CH) 2024-11-06 EP disclosed
CN-117929552-A Method for detecting 55 organic acids and sugar alcohols in urine by gas chromatography-tandem mass spectrometry technology 北京凯莱谱生物科技有限公司 2024-04-26 CN disclosed
EP-3110532-B1 SYSTEMS FOR UTILIZING THE WATER CONTENT IN FLUID FROM A RENAL REPLACEMENT THERAPY PROCESS AQUAPORIN AS (DK) 2024-01-10 EP disclosed
WO-2023126758-A1 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE Société des Produits Nestlé S.A. (CH) 2023-07-06 WO disclosed
EP-4073242-A1 COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE ACTIVITY Kumquat Biosciences Inc. (US) 2022-10-19 EP disclosed